Ацитретин/этретинатная эмбриопатия

A rare teratogenic disorder due to acitretin or etretinate exposure during the first trimester of pregnancy, carrying a risk of fetal malformations of approximately 2%, including central nervous system, craniofacial, ear, thymic, cardiac and limb anomalies.